Anonymous
Guest
Anonymous
Guest
Has anyone heard details about severance packages and a specific date the RIF will occur ?and
10-19
Has anyone heard details about severance packages and a specific date the RIF will occur ?and
Amgen may suck when it comes to internal drug discovery but it also has a history of terrible acquisitions and in-licencing. Tularik, Ilypsa, Alantos, Abgenix etc. Total waste of money
They may have paid too much for Immunex to get Enbrel but they aquired some outstanding discovery research scientists who really knew how to come up with new targets. The really sad thing about this round of layoffs is that due to the "realigning" of R&D they will be getting rid of some very good scientists unlike the RIFs in 2007 where the weakest were culled. There is no way that Amgen will ever regain any sort of inhouse capacity for discovery, they are now just one of many biosimilar me-too companies.
You guys should start #Occupy Amgen until Kevin goes Steven Job's style and takes a $1 annual salary and gives the rest of his compensation to eliminate the lay-offs.
KS and RP have the best interests of Amgen and the people that work for Amgen in mind.
This was a difficult decision for both of them. While the words ring hollow after such an announcement, please know that KS and RP spent many a sleepless night on the beach trying to come up with ways to keep the layoffs from happening.
"We will not do violence to R&D"
I salute them both.
KS and RP have the best interests of Amgen and the people that work for Amgen in mind.
This was a difficult decision for both of them. While the words ring hollow after such an announcement, please know that KS and RP spent many a sleepless night on the beach trying to come up with ways to keep the layoffs from happening.
"We will not do violence to R&D"
I salute them both.
ATO inflammation gone.
ATO inflammation gone.
If they cut the fat (middle management) they could keep the meat of R&D but I guess that makes way too much sense!
It doesn't make sense. A bunch of soldiers running around with their heads cut off.
You need a couple of leaders to keep them focussed.
Rumors say: 30% Inflammation research, 50% Hem/Onc research (Hem hardest hit), 8% Metabolic research plus others. Layoffs next week.